ABOUT US
PENICILLIN GENERAL INTEGRATED INDUSTRIAL COMPANY (FZC) LLC is an Oman based Limited Liability Company setting up a state-of-art fermentation plant for the manufacturing of Penicillin G and 6-APA, a key chemical compound in the most widely used group of antibiotics.
We are the first and only biotechnology manufacturing facility in the entire MENA region for Penicillin-G. The facility has been designed to have two blocks for the manufacture of Penicillin-G and 6-APA (Amino Penicillanic Acid). These are key start-up materials for the most widely used group of antibiotics. Furthermore, the plant has been designed from the ground up to comply wholly with Good Manufacturing Practices (GMP), ensuring all products manufactured are to global standards and regulations.
This project is jointly owned by Mohsin Haider Darwish Group (MHD), a one of the largest and pioneering business houses in Sultanate of Oman and Mr. Ali Moosa Al Bulushi, a proven, dynamic, strategic partner, multi-discipline, project director and program manager for setting up various pharmaceutical companies in Sultanate of Oman.
Our mission
At Pen-G, our mission is to provide high-quality pharmaceutical products that improve patient outcomes, uphold ethical standards, and contribute to a healthier society.
Our Vision
Our vision is to be a global leader in antibiotic manufacturing, recognized for our commitment to quality, regulatory compliance, innovation, sustainability and excellence in pharmaceuticals.
Supporting OMAN VISION 2040
Pen-G is proud to contribute to Oman Vision 2040 by providing essential pharmaceutical chemicals key starting material critical in the production of antibiotics like Penicillin G and 6-APA. Aligned with the vision’s healthcare goals, we prioritize the supply of high-quality pharmaceuticals to empower local manufacturing and enhance healthcare accessibility across Oman.
Enabling Local Antibiotic Production
As Oman strives for self sufficiency in healthcare, Pen G's provision of key starting material like Penicillin G & 6-APA enables local production of antibiotics, thereby strengthening Oman's healthcare infrastructure and fostering medical independence.
Investing in Healthcare Infrastructure
Pen-G's commitment to Oman Vision 2040 extends beyond supplying pharmaceutical chemicals. We collaborate with local pharmaceutical companies and healthcare institutions to bolster manufacturing capabilities and enhance healthcare services. By investing in infrastructure and technology, we contribute to the vision's goal of building a robust and sustainable healthcare ecosystem for the benefit of all Omanis.
Partnering for a Healthier Future
Together with Oman Vision 2040, Pen-G envisions a future where healthcare is accessible to all. By providing key starting material fostering local manufacturing, we play a vital role in building a healthier nation. Through continued partnership and collaboration, we are committed to advancing Oman's healthcare goals and creating a brighter future for generations to come.
In-Country Value 2040
The Ministry of Energy and Minerals formed the ICV committee to boost Oman’s oil and gas sector’s socio-economic impact. The committee, comprising government and industry members, guides ICV development and coordinates initiatives. Supporting sub-committees focus on procurement and workforce development. Successful initiatives include enhancing local workforce skills and sourcing, and improving the business environment. The industry prioritizes ICV, implementing joint supplier registration and standardizing ICV in tenders. A comprehensive study aims to double the current ICV contribution by 2040, identifying new development opportunities and workforce needs
Our Mission
Developing a competitive and sustainable local supply market:goods, services and skills... TOGETHER!
Our Strategy
To further leverage oil and gas industry joint efforts and initiatives to progressively and effectively develop the Omani supply market and enhance the ICV development environment.
Pen-G IN-COUNTRY VALUE
Pen-G (ICV) programs aim to support the national industry and redirect a larger portion of procurement and service expenses to the national economy. It aims to stimulate and attract foreign investments, diversify the economy, create valuable job opportunities in the private sector and contribute to the growth of the national gross domestic product.
ICV Strategy
Prioritizing In-Country Value builds more resilient economies that benefit all, the prosperity the local economy is evident by:
- Increasing the Omanisation rate and developing the skills of the national workforce and creating valuable job
opportunities in the SME sector. - Increase internal spending on local goods and services, an initiative to support local SME sector in all sectors.
Objectives
The programme aims to achieve the following goals:
- Enhancing spending on research and development (R&D) and advanced technology.
- Creating valuable job opportunities and sponsoring and empowering talented people (scholarships, innovative
training programs). - Social entrepreneurship, by supporting community service programs society segments (people with disabilities
and special needs, students, people with limited income, innovators and health care awareness education).
BOARD OF DIRECTORS

Mohammed A. Al Kharusi
Chairman and Board Of Director
Mohammed A. Al Kharusi
Chairman and Board Of Director
He is currently the Group Chief Investment Officer of Mohsin Haider Darwish (MHD) LLC, holds board positions in various companies engaged in business sectors such as aviation, tourism, oil and gas, manufacturing, education, logistics, pharmaceutical, construction, financing and non-banking financial institution. He is also an active board member of Oman Bahrain Friendship Association, Oman-French Friendship Association and Oman-Swiss Friendship Association.
He is a Certified Risk Analyst (CRA) from the American Academy of Financial Management and a Certified Investment Consultant from Citibank Certification Program. He has a wealth of experience that spans over 25 years in financial management with demonstrated skills in credit risk evaluation, strategic planning, developing solid relationships and managing profitable growth while overseeing large portfolios. He holds an MBA from the University of Maryland, USA and completed his Baccalaureate Degree in Management Information System / Business Management from Maryville University, USA.

Ali Moosa Al Bulushi
Chief Executive Officer and Board Of Director
Ali Moosa Al Bulushi
Chief Executive Officer and Board Of Director
He is a proven, dynamic, multi-disciplined project director and program manager. He was a banker for close to 2 decades before he plunged into the pharmaceutical business. With his rich banking experience combined with his passion for pharma industry, he successfully implemented and provided complete project life-cycle management services for various pharma projects in India and Oman.
Penicillin G, the new venture is part of his constantly evolving dream to build value in the pharma sector towards Oman’s Vision 2040. Penicillin G represents value addition at the raw material stage of antibiotic medicine manufacturing- an area dominated by China.

Rajesh Soman
Board Of Director
Rajesh Soman
Board Of Director
Rajesh Soman is a Chartered Accountant from India with 25 years of regional and international experience possessing broad range of management, operational and strategic skills in managing business operations of large family businesses with international presence.
Rajesh has worked in multiple domains, geographies in C-Suite positions. Currently CFO at Mohsin Haider Darwish, one of the leading well diversified family conglomerates based in Muscat with presence in the Gulf countries.

Hanoz Ahmed
Board Of Director
Hanoz Ahmed
Board Of Director
Hanoz Ahmed is an ACCA and Postgraduate in Business Management by qualification. He possesses a plethora of experience in the national & international finance spectrum across steel, environment, trading and financial services sectors in India and Oman that comprises a period of over 25 years.
He has spent over 15 years within the Mohsin Haider Darwish Group and heads the Family Office, overseeing a diverse & extensive portfolio of responsibilities including new project opportunities and investments.
CORE TEAM

Sathish Rajan
Chief Operating Officer
Sathish Rajan
Chief Operating Officer

Ramakrishna Konakandla
Finance Head
Ramakrishna Konakandla
Finance Head

Kaushalendra Mishra
Technical Head
Kaushalendra Mishra
Technical Head
OUR SHAREHOLDERS

Mohsin Haider Darwish L.L.C.
MHD has been a strong contributor to the economy of Oman in the last few decades, committed through waves of growth and development. While we are witnessing the change, currently sweeping through our communities, be it in the businesses we operate, the societies we live in or the global realities of today, we also feel a strong sense of a momentous drive promising a new way forward.
Opportunities are opening up for reliable and efficient transportation, effective communication, dependable infrastructure, better healthcare and living. In all areas, MHD has delivered success and built value over the years. MHD has the strength of legacy and the spirit of ambition to leverage these opportunities. Together with our partners and people, we will continue to inspire progress that will build meaningful values for future generations. With our network and presence, we will collaborate with local businesses to build capability, identify and hone talent and co-create innovative solutions.

Mr. Ali Moosa Al Bulushi
He is a proven, dynamic, multi-disciplined project director and program manager. He was a banker for close to 2 decades before he plunged into the pharmaceutical business. With his rich banking experience combined with his passion for pharma industry, he successfully implemented and provided complete project life-cycle management services for various pharma projects in India and Oman.
Penicillin G, the new venture is part of his constantly evolving dream to build value in the pharma sector towards Oman’s Vision 2040. Penicillin G represents value addition at the raw material stage of antibiotic medicine manufacturing- an area dominated by China.
Sustainability & Responsibility
At Pen-G, we’re deeply committed to sustainability and responsibility in every facet of our operations. From our manufacturing processes to sourcing practices, we prioritize environmental stewardship. We invest in energy-efficient technologies, waste reduction strategies, and ethical sourcing to minimize our environmental impact and support social equity. Community engagement is at the core of our ethos, as we actively participate in local initiatives to uplift healthcare, education, and environmental conservation efforts.

Employee Well-being and Ethical Practices
Our dedication extends to the well-being of our employees, ensuring a safe and supportive work environment. We adhere to strict health and safety standards and promote a culture of respect and inclusivity. Ethical practices drive our sourcing decisions, ensuring fair labor practices and environmental sustainability across our supply chain. At Pen-G, sustainability and responsibility are not just aspirations; they’re fundamental principles guiding our journey towards a brighter, more equitable future.